Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: December-11-09
Credit Expiration Date: December-11-10

Faculty

Robert G. Miller, MD, FAAN
Director of Neuromuscular Research
Clinical Professor of Neurology
University of California
San Francisco, CA

and

Gary Gronseth, MD, FAAN
Vice Chairman, Department of Neurology
Professor of Neurology
University of Kansas School of Medicine
Kansas City, KS

Credit Hours

1

Medium

Online Presentation

Program Description

THIS ACTIVITY WAS ORIGINALLY PRESENTED AS A LIVE LUNCH AND LEARN AUDIOPRESENTATION ON NOVEMBER 4, 2009. IF YOU EARNED CME/CE CREDIT FOR THE AUDIOCONFERENCE YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE RELEASE.

This presentation will provide an overview of the best available evidence for the care of patients with amyotrophic lateral sclerosis (ALS), as outlined in two recently published American Academy of Neurology (AAN) guidelines. Robert G. Miller, MD, AAN Fellow and lead guideline author, will highlight the strongest recommendations and will describe how they fit in the context of real-world clinical practice. Gary S. Gronseth, MD, AAN Fellow and evidence-based medicine consultant, will provide a brief overview of the AAN guideline development process at the start of the presentation.

NEW GUIDELINES ARE AVAILABLE FROM AAN:
Guideline 1
Guideline 2

Program Developer/Facilitator


.

Target Audience

This program has been developed for neurologists and nurses.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Identify clinical applications in neurology that are relevant to NINDS studies and other neurologic studies
  2. Discuss the impact of neurologic disease on patients
  3. Cite examples of recent advances in the treatment of neurologic disease

Disclosures

Neither Dr. Miller nor Dr. Gronseth has any relevant commercial interests to disclose.

AKH planners and reviewers have no relevant financial relationships to disclose.

This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

PHYSICIANS: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and the NINDS CRC Operations Center. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc. designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSES: AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centerís COA.

AKH Inc. designates this educational activity for 1.0 contact hour (0.1 CEU). Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.

To receive CME/CE credit, participants must complete the post-test with a passing grade of 80% or better and the program evaluation online. One retake is allowed on the post-test. This activity should take approximately 1 hour to complete.

Certificate Fee

$0.00

Disclaimer

Opinions expressed are those of the speaker and do not necessarily reflect the views of NINDS, the CRC, or AKH Inc.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS